Rathbones Group PLC Increases Stock Position in CME Group Inc. $CME

Rathbones Group PLC grew its stake in shares of CME Group Inc. (NASDAQ:CME) by 1.1% during the 4th quarter, HoldingsChannel reports. The fund owned 999,530 shares of the financial services provider’s stock after buying an additional 10,602 shares during the period. CME Group comprises 1.1% of Rathbones Group PLC’s portfolio, making the stock its 22nd biggest holding. Rathbones Group PLC’s holdings in CME Group were worth $272,952,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. West Family Investments Inc. raised its stake in shares of CME Group by 1.2% during the 3rd quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock valued at $827,000 after purchasing an additional 37 shares during the period. Asset Dedication LLC boosted its stake in CME Group by 64.9% in the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 37 shares during the period. Northwestern Mutual Investment Management Company LLC grew its holdings in CME Group by 0.3% during the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock valued at $3,147,000 after buying an additional 37 shares in the last quarter. Rehmann Capital Advisory Group increased its position in shares of CME Group by 4.3% during the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after buying an additional 37 shares during the period. Finally, Atlatl Advisers LLC increased its position in shares of CME Group by 1.8% during the third quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider’s stock valued at $574,000 after buying an additional 38 shares during the period. 87.75% of the stock is owned by institutional investors.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Neutral Sentiment: Recent market commentary says the stock’s weakness looks consistent with profit-taking after CME’s strong first-quarter results, which included record revenue and better-than-expected earnings. That means investors may be locking in gains after the company set a high bar for continued performance.
• Neutral Sentiment: Macro expectations are also shaping the move: traders are pricing out Federal Reserve rate cuts in 2026, and CME’s business depends heavily on derivatives and rate-volatility activity. If rate uncertainty stabilizes, trading volumes can cool, which may be weighing on the shares.
• Neutral Sentiment: CME recently filed routine annual-meeting shareholder materials, and its adjourned Class B proposals after a quorum shortfall. These governance updates are not likely to change the business outlook, but they can keep investor attention on voting and corporate structure issues. Article Title
• Neutral Sentiment: There was also a notable insider sale by CEO Terrence Duffy and another sale by Hilda Harris Piell. Insider selling often hurts sentiment, but it appears more like a cautionary signal than a direct fundamental warning. Article Title
• Negative Sentiment: Competition in emerging compute-linked futures is also drawing attention, with ICE planning its own computing-power futures market while CME is pursuing similar product expansion. That suggests CME may face pressure to defend its growth opportunities in a new niche. Article Title

Insiders Place Their Bets

In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider owned 27,702 shares in the company, valued at approximately $8,438,860.26. The trade was a 17.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Martin J. Gepsman sold 300 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $305.90, for a total value of $91,770.00. Following the sale, the director directly owned 24,999 shares of the company’s stock, valued at approximately $7,647,194.10. This trade represents a 1.19% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 48,544 shares of company stock worth $14,689,807. 0.30% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Royal Bank Of Canada raised their price objective on shares of CME Group from $295.00 to $302.00 and gave the company a “sector perform” rating in a research report on Thursday, February 5th. Raymond James Financial increased their target price on shares of CME Group from $310.00 to $320.00 and gave the stock an “outperform” rating in a research note on Monday, April 6th. The Goldman Sachs Group cut their price target on shares of CME Group from $275.00 to $267.00 and set a “sell” rating for the company in a report on Thursday, April 23rd. Morgan Stanley reduced their price target on shares of CME Group from $362.00 to $353.00 and set an “overweight” rating for the company in a research report on Thursday, April 23rd. Finally, Piper Sandler increased their price objective on CME Group from $313.00 to $329.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 15th. Two research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, CME Group has a consensus rating of “Moderate Buy” and an average target price of $305.29.

CME Group Stock Down 4.1%

CME stock opened at $290.12 on Thursday. The company’s 50 day moving average is $296.96 and its 200 day moving average is $288.93. The stock has a market cap of $105.13 billion, a price-to-earnings ratio of 24.75, a price-to-earnings-growth ratio of 3.66 and a beta of 0.23. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 1-year low of $257.17 and a 1-year high of $329.16.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The company had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. During the same period in the previous year, the firm posted $2.80 EPS. The firm’s revenue was up 14.5% compared to the same quarter last year. Sell-side analysts predict that CME Group Inc. will post 12.26 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be given a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.8%. The ex-dividend date is Tuesday, June 9th. CME Group’s dividend payout ratio (DPR) is presently 44.37%.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.